Deerfield Management Company, L.P. (Series C) Ptc Therapeutics, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$4.35 Billion
Q2 2025

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $15.2 Million - $23.6 Million	-471,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $8.29 Million - $10.5 Million	234,000 Added 98.73%	471,000 $21.2 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $6.66 Million - $9.36 Million	237,000 New	237,000 $8.92 Million

Others Institutions Holding PTCT

# of Institutions

312

Shares Held

79.5M

Call Options Held

255K

Put Options Held

151K

Vanguard Group Inc Valley Forge, PA

8.85M
Shares

$603 Million
0.01% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$529 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.75M
Shares

$528 Million
5.81% of portfolio
Armistice Capital, LLC New York, NY

4.74M
Shares

$323 Million
4.05% of portfolio
Wellington Management Group LLP Boston, MA

4.69M
Shares

$320 Million
0.04% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $4.87B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account